Cellular therapies for chronic ischemic heart failure
نویسندگان
چکیده
منابع مشابه
Emerging Drug Therapies for Heart Failure
Heart failure is associated with high morbidity and mortality and is proving to be an economic burden in developing countries. A number of therapeutic agents are presently employed in heart failure; but they are not sufficient to control symptoms of heart failure. Moreover, the prevalence of chronic heart failure is progressively increasing and thus there is a continuing need to develop effecti...
متن کاملNovel Therapies for Heart Failure
February is chosen by both the American Heart Association and British Heart Foundation as the month for heart awareness, and we dedicate this month's editorial to heart failure (HF) — a common and debilitating condition in which unmet medical needs remain globally. HF is a leading cause of hospitalization in people over 65 years of age, andmore than half the patients diewithin 5 years of diagno...
متن کاملWomen, heart failure, and heart failure therapies.
The landmark 2001 Institute of Medicine (IOM) report Exploring the Biological Contributions to Human Health: Does Sex Matter?1 confirmed that significant differences between the sexes affect the prevalence, incidence, and severity of a broad range of diseases and conditions. The report highlighted that sex differences must be considered when designing and analyzing research studies in all areas...
متن کاملIschemic Heart Disease & Chronic Heart Failure in the Elderly
Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure – C. Chimenti and others Age-dependent impairment of angiogenesis – A. Rivard and others Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-1 trial – H. D. White and others Age-related increase in mortality among patients with first myocardial infarctions treated wi...
متن کاملDelivering Electrical Therapies for Heart Failure
Implantable devices have become a readily available option for patients with heart failure. Not only do these patients develop bradycardia and ventricular tachycardia, but their ventricular dysfunction can often improve with cardiac resynchronization therapy. However, this is a complex and rapidly developing clinical science for which the physician chooses techniques and selects patients on the...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Hellenic Journal of Cardiology
سال: 2018
ISSN: 1109-9666
DOI: 10.1016/j.hjc.2018.01.010